Latest Breaking News On - Head of the department pediatric nephrology - Page 1 : vimarsana.com

Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1 - read this article along with other careers information, tips and advice on BioSpace

United kingdomUnited statesFrance generalNoord hollandPushkal gargJaap groothoffUniversity of amsterdamDrug administrationAlnylam pharmaceuticals incExchange commissionAlnylam pharmaceuticalsInternational congressAmerican society of nephrologyHead of the department pediatric nephrologyEuropean medicines agencyEuropean renal association